Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

First ACC/AHA acute pulmonary embolism guidelines include new categories for risk stratification

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.

The new guidance, the first of its kind, focuses on the importance of making a prompt diagnosis and providing care as quickly as possible. While some PE patients with mild cases can be discharged early, others may require an immediate catheter-based intervention or surgery.

  • Read more about First ACC/AHA acute pulmonary embolism guidelines include new categories for risk stratification

Heart failure company BioVentrix files for IPO

BioVentrix's Revivent system

Graphic courtesy of BioVentrix.

The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.

  • Read more about Heart failure company BioVentrix files for IPO

Gore completes acquisition of medtech company behind next-gen heart device

Conformal Medical CLAAS

Image courtesy of Conformal Medical.

Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.

  • Read more about Gore completes acquisition of medtech company behind next-gen heart device

Medtronic’s RDN system receives new reimbursement approval

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

The Symplicity Spyral RDN system. Graphic courtesy of Medtronic.

More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

  • Read more about Medtronic’s RDN system receives new reimbursement approval

Statin labeling should be revised with updated warnings, meta-analysis confirms

Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.

Researchers explored data from more than 123,000 patients, noting that dozens of the adverse complications included on current labels can safely be removed. 

  • Read more about Statin labeling should be revised with updated warnings, meta-analysis confirms

Esperion settles another lawsuit to keep generic versions of popular drug off shelves

Esperion Therapeutics Inc. has filed patent infringement lawsuits against eight generic drug makers for filing U.S. Food and Drug Administration (FDA) abbreviated new drug applications (ANDA) to make generic versions of its successful bempedoic acid (Nexletol).

As soon as Esperion Therapeutics gained FDA clearance for Nexletol in 2020, competitors started trying to copy it. The company is fighting back. 

  • Read more about Esperion settles another lawsuit to keep generic versions of popular drug off shelves

Cardiologist develops new heart device that uses gel to reduce stroke risk in AFib patients

After years of implanting left atrial appendage occlusion (LAAO) devices in atrial fibrillation (AFib) patients, an interventional cardiologist with the University of Chicago Medical Center (UChicago Medicine) has developed a new device that could be a more affordable alternative to Boston Scientific’s Watchman and Abbott’s Amplatzer Amulet LAA Occluder.

Image courtesy of UChicago.

After years of implanting and studying LAAO devices, an interventional cardiologist with the University of Chicago has designed a new alternative that could reduce the risk of bleeding and save health systems money.

  • Read more about Cardiologist develops new heart device that uses gel to reduce stroke risk in AFib patients

PAD patients could be missing out on recommended care following major lower extremity amputations

leg amputation below the knee

Patients undergoing the procedures due to infection, chronic limb-threatening ischemia and other serious complications may not be receiving the follow-up care their need.

  • Read more about PAD patients could be missing out on recommended care following major lower extremity amputations

How hypertension during pregnancy impacts a woman's long-term cardiovascular health

Michael Honigberg, MD, MPP, a preventive cardiologist and cardiovascular researcher at Massachusetts General Hospital, explains how preeclampsia and gestational hypertension during pregnancy can elevate cardiovascular risks later in life and how to best manage these patients.

Emerging research suggests that the early postpartum period may represent a critical window for influencing a woman's long-term cardiovascular health. 

  • Read more about How hypertension during pregnancy impacts a woman's long-term cardiovascular health

Cardiology, cardiac imaging groups support new bill delaying cuts to physician pay

money cost cutting Medicare scissors dollar economics

Nearly 40 healthcare organizations signed a letter in support of the bipartisan legislation, noting that Medicare's “efficiency adjustment” decreases reimbursement during a challenging time for physicians.

  • Read more about Cardiology, cardiac imaging groups support new bill delaying cuts to physician pay

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …61
    • Page 62
    • Page 63
    • Page 64
    • Current page 65
    • Page 66
    • Page 67
    • Page 68
    • Page 69 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme